about
Retrospective evaluation of occupational exposures in cancer epidemiology: a European concerted action of researchEuropean Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary documentAccuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trialEpidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review.European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.A high positive predictive value algorithm using hospital administrative data identified incident cancer cases.Population based cancer screening programmes as a teachable moment for primary prevention interventions. A review of the literature.Compliance with clinical practice guidelines for breast cancer treatment: a population-based study of quality-of-care indicators in ItalyDifference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial.International variation in management of screen-detected ductal carcinoma in situ of the breast.Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial.Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy.HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology.Do women >or=50 years of age need as much screening as women <50 years after they have had negative screening results?Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction.Improving the quality of communication in organised cervical cancer screening programmes.Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination.Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.Acceptability and side-effects of colonoscopy and sigmoidoscopy in a screening setting.Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.CT colonography: preliminary assessment of a double-read paradigm that uses computer-aided detection as the first reader.Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.Computer-aided detection for computed tomographic colonography screening: a prospective comparison of a double-reading paradigm with first-reader computer-aided detection against second-reader computer-aided detection.Optimising colorectal cancer screening acceptance: a review.Absence of socioeconomic inequalities in access to good-quality breast cancer treatment within a population-wide screening programme in Turin (Italy).Accessibility as a major determinant of radiotherapy underutilization: a population based study.The EUROMED CANCER network: state-of-art of cancer screening programmes in non-EU Mediterranean countries.European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Principles of evidence assessment and methods for reaching recommendations.Determinants of successful implementation of population-based cancer screening programmes.Baldness and testicular cancer: the EPSAM case-control study.Cervical cancer screening. Human benefits and human costs in the evaluation of screening programmes.Cervical cancer screening in Italy.What information do breast cancer screening programmes provide to Italian women?The impact of different communication and organizational strategies on mammography screening uptake in women aged 40-45 years.Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis.Modelling patterns of clearance of HPV-16 infection and vaccination efficacy.Cervical screening according to age and HPV status.The differential diagnosis of primary lung cancer: inter-observer agreement and contribution of specific diagnostic procedures.Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
P50
Q23912023-53FF2635-8B73-490F-A2FC-EFA02AA8DB3BQ24644710-5BF3DB4A-0381-4867-BB97-6B3D5F13BEC3Q24679201-43F9E26E-C456-4984-BF26-9AC34DAD8647Q30251732-B8FBFEAF-BBD6-4661-AEDB-9E6F73B3DC41Q30485842-9DA6E394-87EE-44F8-A7C0-D4E700DCE529Q31148291-83175EBF-76A6-464A-94D3-61B5CD54EC5DQ34287734-EC4DC496-5875-46D0-9382-D8B85E3148D1Q34564115-05F49BB2-9FAC-4A27-B25C-FF025DA30ADDQ34739688-4143F12F-381E-41EF-A4CA-C6CCF606C51EQ34764889-1F63F17D-FC10-478E-8A1D-C1970389C0E8Q35117225-03643A8D-4C74-48A2-851C-C685115C3432Q35633665-ECD29C5A-5914-4FFD-A5C1-F3FE91B98A1BQ36708180-A848F4CF-7D93-4C4C-AA5C-AD3DF6117866Q36785978-C6596D9A-985F-45A6-8C37-27873038EC9DQ36858064-B144F6D6-4AB0-4916-96B6-95A38873C243Q37185864-4E710F37-DD30-453F-9684-B57AB0DEEE78Q37265745-01485E90-FFF2-4BEA-B889-FEC0D22AE192Q37583227-FCE3A931-B6AA-4756-AF9B-6A9E8B0A6A33Q37688398-C546F76D-04B3-47F2-A388-C9466CB50CA9Q37951885-EC24F2E7-F5CC-4F53-AA89-FD20C900CB41Q38042896-D74231FC-754F-4BF4-9D49-5D2A60FDE9C1Q38102975-368F6044-498A-496C-B24E-465EFC07616EQ38160099-E93D32E7-5AB7-46ED-B876-AB986A6B179EQ38179967-E10F0B42-2BDA-4E30-8FBA-38EF32D83520Q38389267-39B5686B-12E5-49B6-92F6-DF6B2B589F1AQ38409055-A8D8741A-215E-4009-8391-332AD0F4E0D2Q38452710-BA6ADE05-2821-46CD-9E3A-66AFA611625DQ39024373-D835339A-9FFC-4D28-A78B-C9887B4C4038Q39543652-ACE01B33-A794-4031-834B-F50355A7A89EQ39724938-2028AA71-5E9A-418D-AF05-BC98D118B8B1Q39949220-F5370453-B8A0-4A81-AF79-85ED0BB30084Q40626610-6442FC3F-45BE-4E1C-AB81-1ED6577D8ECCQ40739437-CB543A9E-D4E9-41E9-926B-C9EE2653F13EQ42651581-BE0AF110-7AD6-4BF3-A419-AA1456BABF47Q43664920-DB775E51-7B41-409E-903B-72CB752A6AB0Q43791052-5BE49565-ACF8-4CED-8185-6A9163EB3670Q43946877-23C10A66-325E-4BB9-A0D5-86BE8E4978C5Q44458983-353878FB-20CA-4824-98CD-F01B6F40A5C8Q44778192-5158B26D-2A7A-447A-9D15-05FDF927984DQ44817741-C35B62F4-2280-4868-ABE7-0085F5C1591A
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Nereo Segnan
@ast
Nereo Segnan
@en
Nereo Segnan
@es
Nereo Segnan
@nl
Nereo Segnan
@sl
type
label
Nereo Segnan
@ast
Nereo Segnan
@en
Nereo Segnan
@es
Nereo Segnan
@nl
Nereo Segnan
@sl
prefLabel
Nereo Segnan
@ast
Nereo Segnan
@en
Nereo Segnan
@es
Nereo Segnan
@nl
Nereo Segnan
@sl
P1006
P214
P244
P1006
P106
P1153
7003900032
P21
P213
0000 0001 1941 560X
P214
P244
no2011069505
P31
P496
0000-0002-4730-5384
P569
2000-01-01T00:00:00Z
P735
P7859
lccn-no2011069505